Trials / Completed
CompletedNCT00831662
The Effects of Diquafosol Tetrasodium Ophthalmic Solution, 2% in Subjects With Dry Eye Disease (P08637)
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 490 (actual)
- Sponsor
- Merck Sharp & Dohme LLC · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to confirm the safety and efficacy of diquafosol tetrasodium ophthalmic solution, 2% vs. placebo, in subjects with dry eye disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Diquafosol tetrasodium ophthalmic solution, 2% | One to two drops in each eye QID for 6 weeks |
| DRUG | Placebo | One to two drops in each eye QID for 6 weeks |
Timeline
- Start date
- 2009-01-01
- Primary completion
- 2009-12-01
- Completion
- 2009-12-01
- First posted
- 2009-01-29
- Last updated
- 2015-01-09
Source: ClinicalTrials.gov record NCT00831662. Inclusion in this directory is not an endorsement.